Safety and efficacy of bidirectional chemotherapy for treatment of patients with peritoneal dissemination from gastric cancer: Selection for cytoreductive surgery.
about
Chemotherapy for intraperitoneal use: a review of hyperthermic intraperitoneal chemotherapy and early post-operative intraperitoneal chemotherapyMilky spots: omental functional units and hotbeds for peritoneal cancer metastasisAdvanced gastric cancer: What we know and what we still have to learnCytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancerOutcome data of patients with peritoneal carcinomatosis from gastric origin treated by a strategy of bidirectional chemotherapy prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a single specialized center in Japan.Aggressive locoregional surgical therapy for gastric peritoneal carcinomatosis.Primary retroperitoneal mullerian adenocarcinomaMultidisciplinary therapy for treatment of patients with peritoneal carcinomatosis from gastric cancer.Systematic review of intraperitoneal chemotherapy for gastric cancer.Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial.Benchmarking of gastric cancer sensitivity to anti-cancer drugs ex vivo as a basis for drug selection in systemic and intraperitoneal therapyEffects of neoadjuvant intraperitoneal/systemic chemotherapy (bidirectional chemotherapy) for the treatment of patients with peritoneal metastasis from gastric cancer.Efficacy of paclitaxel-based doublet regimens combining with intraperitoneal chemotherapy for advanced gastric cancer with peritoneal metastasis.The Role of Hyperthermic Intraperitoneal Chemotherapy in Gastric Cancer.Survival benefit of gastrectomy for gastric cancer with peritoneal carcinomatosis: a propensity score-matched analysis.Primary retroperitoneal müllerian adenocarcinoma: a case report and literature review.Gastric peritoneal carcinomatosis - a retrospective review.Treatment of gastric cancer with peritoneal carcinomatosis by cytoreductive surgery and HIPEC: a systematic review of survival, mortality, and morbidity.Peritoneal carcinomatosis: cytoreductive surgery and HIPEC--overview and basics.Pharmacokinetics and pharmacodynamics of intraperitoneal cancer chemotherapeutics.Drug development for intraperitoneal chemotherapy against peritoneal carcinomatosis from gastrointestinal cancer.Peritoneal cancer treatment.The treatment of peritoneal carcinomatosis in advanced gastric cancer: state of the art.Treatment of Peritoneal Dissemination in Stomach Cancer Patients With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Rationale and Design of the PERISCOPE Study.Ninety percent of the adverse outcomes occur in 10% of patients: can we identify the populations at high risk of developing peritoneal metastases after curative surgery for colorectal cancer?Intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis.Potentiation of chemotherapeutics by bromelain and N-acetylcysteine: sequential and combination therapy of gastrointestinal cancer cells.Selection criteria for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancer.Hyperthermic intraperitoneal perfusion chemotherapy and response evaluation in patients with gastric cancer and malignant ascites.Cathepsin B cleavable novel prodrug Ac-Phe-Lys-PABC-ADM enhances efficacy at reduced toxicity in treating gastric cancer peritoneal carcinomatosis: an experimental study.The effect of extensive intraoperative peritoneal lavage therapy (EIPL) on stage III B + C and cytology-positive gastric cancer patients.Unresectable gastric cancer with gastric outlet obstruction and distant metastasis responding to intraperitoneal and folfox chemotherapy after palliative laparoscopic gastrojejunostomy: report of a case.Prognostic factors in patients with loco-regionally advanced gastric cancer.Surgical results of patients with peritoneal carcinomatosis treated with cytoreductive surgery using a new technique named aqua dissection.Morbidity and mortality outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at a single institution in Japan.Initial clinical experience with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in signet-ring cell gastric cancer with peritoneal metastases.A phase 2 trial of intravenous and intraperitoneal paclitaxel combined with S-1 for treatment of gastric cancer with macroscopic peritoneal metastasis.Treatment outcomes of systemic chemotherapy for peritoneal carcinomatosis arising from gastric cancer with no measurable disease: retrospective analysis from a single center.Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites.Clinical studies in CRS and HIPEC: Trials, tribulations, and future directions-A systematic review.
P2860
Q26768402-0D2B15F1-8429-4F6D-B533-25F6A2FE1FF7Q26772888-C915D693-202A-4E88-9D8D-D15E5E1B9CC1Q26774528-9D7E24C8-25B8-4AF9-8CBA-C06A6EF32417Q26774538-49FFDC99-4FA2-48EB-B378-E32DF49CDEF3Q30719628-80144015-3645-42D1-BFBB-F1D17600868AQ34015030-C5796004-0739-432C-9CAD-71893C30091DQ34364812-9AE3B06E-19A8-453E-9923-13D597756C2BQ34390124-803A580F-C068-485D-BF28-62CBC99D8CAEQ34629897-AB61836C-915F-4FD2-8779-9C0B14A6FCF4Q34928467-5C7F29C2-BAC4-41F3-876F-F58CBF91C7DFQ35005019-2D691EC4-EDDC-42C9-AE6E-4315DD041427Q36151519-25924B06-08D1-43F7-B357-B4A1665CA434Q36411935-FBCDE3E9-2F16-44CC-972B-FC6C86032703Q36758921-D3938FC5-3E87-4984-B060-8D67E43F70A6Q37373079-302C5C2B-955F-4A0B-AA83-357AB73EC7BAQ37513889-9D9A754D-F789-45FE-82EB-CFE69C9D8335Q37697571-8AF02C3F-BC00-4597-9F32-5212B4700CC5Q37895575-C7918A41-9B67-49EE-934B-80015C09614AQ37987561-56FC9610-E0BD-42AA-A7BD-EF72B80DCD6AQ37993908-49379DF8-2ABB-4536-A49A-227618B58BA3Q38183786-C76847A8-875C-4016-A433-D62D4725AEEEQ38195114-8EC466C8-DF1A-4ED5-972B-09143DA2A021Q38201470-EEE28101-98B8-443C-A3F8-03D7C8BE8A88Q38373169-183BB2A4-F029-460C-BB28-0F5FD5BFCEA9Q38765795-4C915971-B3CD-43B7-913D-F9DF368B86A4Q38800565-B5FE1D29-2EED-4C10-A16E-144D2A770B04Q38866435-BC083B5B-2EFD-42BF-9EB2-10132C442584Q38944087-53BA6E74-005C-480C-B671-FED71EF74797Q39151711-E25A1D61-C4EA-47A0-8B98-CB78B0F666A3Q39456682-28522856-6C36-4522-9C3F-7101286F2B60Q41462800-4EC43FD1-5BC2-4D3F-9D7E-ABC580221FCFQ41610787-6B2F315D-9A69-4BF5-A1E7-911220D05122Q41718964-85B77911-C15F-46DF-8F0F-453D04ADA408Q41828967-B76ED497-28C6-4107-A997-CB5B4E9142DDQ42218638-646BA97A-5CB1-4DC1-BBA5-3ECBC639F09EQ42238544-10644724-C37D-42D8-B466-D54504A55D24Q44607992-CD98B1FC-02E0-4594-A3F9-3B94909C9C94Q45027842-CA2A8965-207C-4CCC-B51A-1E566202BE45Q46170838-91339EAA-4742-40A1-B872-1B120841A2E0Q47849422-A7236D93-D88F-4767-A83B-BE876EA2F432
P2860
Safety and efficacy of bidirectional chemotherapy for treatment of patients with peritoneal dissemination from gastric cancer: Selection for cytoreductive surgery.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Safety and efficacy of bidirec ...... ion for cytoreductive surgery.
@en
Safety and efficacy of bidirec ...... ion for cytoreductive surgery.
@nl
type
label
Safety and efficacy of bidirec ...... ion for cytoreductive surgery.
@en
Safety and efficacy of bidirec ...... ion for cytoreductive surgery.
@nl
prefLabel
Safety and efficacy of bidirec ...... ion for cytoreductive surgery.
@en
Safety and efficacy of bidirec ...... ion for cytoreductive surgery.
@nl
P2093
P356
P1476
Safety and efficacy of bidirec ...... ion for cytoreductive surgery.
@en
P2093
Akiyoshi Mizumoto
Gou Nakajima
Hironobu Kimura
Jou Yonemura
Makoto Ikeda
Masahiro Miura
Masamitu Hirano
Masaya Shinbo
Masumi Ichinose
Mitsukuni Mizuno
P304
P356
10.1002/JSO.21324
P577
2009-09-01T00:00:00Z